Leica Biosystems, a Danaher company, announced an expansion of its strategic collaboration with AstraZeneca and Daiichi Sankyo to develop an IHC assay and image analysis algorithm, specifically for the TROP2 NMR biomarker in non-small cell lung cancer, for use as a research tool only.
